M-GAGER Trademark
M-GAGER is a USPTO trademark filed by CDR-Life AG. Status: Registered.
Trademark Facts
| Mark | M-GAGER |
|---|---|
| Serial Number | 97334920 |
| Registration Number | 7186176 |
| Status | Registered |
| Filing Date | 2022-03-28 |
| Registration Date | 2023-10-10 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | CDR-Life AG |
| Attorney of Record | David M. Kelly |
| Prosecution Events | 27 |
| Latest Event | COAR on 2023-12-07 |
Goods & Services
Biochemical preparations for medical use, namely for use in the treatment of cancer; Biological preparations for medical purposes, namely for use in the treatment of cancer; biotechnological products for medical use, namely medical preparations for the treatment of cancer; Pharmaceuticals for use in the treatment of cancer; Pharmaceutical preparations for use in the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of autoimmune diseases; Anti-inflammatory preparations; Immunostimulants; Medicines for human purposes namely, medicinal preparations for the treatment of cancer; Medicines for veterinary purposes namely, veterinary pharmaceutical preparations for the treatment of cancer; Chemico-pharmaceutical preparations namely, chemical preparations for pharmaceutical or medical purposes, namely for use in the treatment of cancer; Diagnostic agents for medical use; Pharmaceuticals, medical and veterinary preparations, namely pharmaceutical preparations for use in the treatment of cancer | Scientific and medical research and development in the field of cancer; Biological and chemical research; Research relating to biotechnology; Pharmaceutical research and development; Research and development services in the field of immunology; Laboratory analysis in the field of molecular biology; Provision of information relating to medical and veterinary research and development in the field of cancer; Consultancy in the field of pharmaceutical research; Consultancy relating to research and development in the field of therapeutics; consultancy relating to biotechnology; Scientific laboratory services; Analytical laboratory services, namely, laboratory analysis in the field of cancer; Services of a chemical or biological laboratory, namely, chemical and biological research and analysis; Research and development services for the pharmaceutical industry; Product development; Quality control for others; Research and development services in the field of antibodies; Scientific research services in the field of proteins, antibodies, microorganisms and cells; Scientific and technological services, namely, scientific analysis and research services in the field of cancer; Chemical analysis; Medical and scientific research, namely, conducting clinical trials for others; Providing of information relating to medical and scientific research on pharmaceutical products